Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Peptic Ulcer

  Free Subscription


Articles published in Helicobacter

Retrieve available abstracts of 166 articles:
HTML format
Text format



Single Articles


    February 2018
  1. WANG YH, Li Z, Wang L, Zhu-Ge LY, et al
    A systematic review and meta-analysis of genotypic methods for detecting antibiotic resistance in Helicobacter pylori.
    Helicobacter. 2018 Feb 6. doi: 10.1111/hel.12467.
    PubMed     Text format     Abstract available


    January 2018
  2. CHOE JW, Jung SW, Kim SY, Hyun JJ, et al
    Comparative study of Helicobacter pylori eradication rates of concomitant therapy vs modified quadruple therapy comprising proton-pump inhibitor, bismuth, amoxicillin, and metronidazole in Korea.
    Helicobacter. 2018 Jan 25. doi: 10.1111/hel.12466.
    PubMed     Text format     Abstract available


  3. BAE SE, Choi KD, Choe J, Kim SO, et al
    The effect of eradication of Helicobacter pylori on gastric cancer prevention in healthy asymptomatic populations.
    Helicobacter. 2018 Jan 18. doi: 10.1111/hel.12464.
    PubMed     Text format     Abstract available


  4. DORE MP, Salis R, Loria MF, Villanacci V, et al
    Helicobacter pylori infection and occurrence of celiac disease in subjects HLA-DQ2/DQ8 positive: A prospective study.
    Helicobacter. 2018 Jan 18. doi: 10.1111/hel.12465.
    PubMed     Text format     Abstract available


  5. LEE JH, Choi KD, Jung HY, Baik GH, et al
    Seroprevalence of Helicobacter pylori in Korea: A multicenter, nationwide study conducted in 2015 and 2016.
    Helicobacter. 2018 Jan 18. doi: 10.1111/hel.12463.
    PubMed     Text format     Abstract available


  6. BOEHNKE KF, Brewster RK, Sanchez BN, Valdivieso M, et al
    An assessment of drinking water contamination with Helicobacter pylori in Lima, Peru.
    Helicobacter. 2018 Jan 8. doi: 10.1111/hel.12462.
    PubMed     Text format     Abstract available


  7. WANG YK, Chiang WC, Kuo FC, Wu MC, et al
    Levels of malondialdehyde in the gastric juice: Its association with Helicobacter pylori infection and stomach diseases.
    Helicobacter. 2018 Jan 5. doi: 10.1111/hel.12460.
    PubMed     Text format     Abstract available


    December 2017
  8. SUE S, Ogushi M, Arima I, Kuwashima H, et al
    Vonoprazan- vs proton-pump inhibitor-based first-line 7-day triple therapy for clarithromycin-susceptible Helicobacter pylori: A multicenter, prospective, randomized trial.
    Helicobacter. 2017 Dec 21. doi: 10.1111/hel.12456.
    PubMed     Text format     Abstract available


  9. CEN L, Pan J, Zhou B, Yu C, et al
    Helicobacter Pylori infection of the gallbladder and the risk of chronic cholecystitis and cholelithiasis: A systematic review and meta-analysis.
    Helicobacter. 2017 Dec 20. doi: 10.1111/hel.12457.
    PubMed     Text format     Abstract available


  10. STENT A, Every AL, Chionh YT, Ng GZ, et al
    Superoxide dismutase from Helicobacter pylori suppresses the production of pro-inflammatory cytokines during in vivo infection.
    Helicobacter. 2017 Dec 13. doi: 10.1111/hel.12459.
    PubMed     Text format     Abstract available


  11. GONZALEZ-PONS M, Soto-Salgado M, Sevilla J, Marquez-Lespier JM, et al
    Seroprevalence of Helicobacter pylori in Hispanics living in Puerto Rico: A population-based study.
    Helicobacter. 2017 Dec 6. doi: 10.1111/hel.12453.
    PubMed     Text format     Abstract available


    November 2017
  12. DOULBERIS M, Kotronis G, Thomann R, Polyzos SA, et al
    Impact of Helicobacter pylori on Alzheimer's disease: What do we know so far?
    Helicobacter. 2017 Nov 27. doi: 10.1111/hel.12454.
    PubMed     Text format     Abstract available


  13. BEER-DAVIDSON G, Hindiyeh M, Muhsen K
    Detection of Helicobacter pylori in stool samples of young children using real-time polymerase chain reaction.
    Helicobacter. 2017 Nov 27. doi: 10.1111/hel.12450.
    PubMed     Text format     Abstract available


  14. MUNOZ-GOMEZ P, Jordan-Castro JA, Abanades-Tercero M, Blanco-Gonzalez JJ, et al
    Macrolide use in the previous years is associated with failure to eradicate Helicobacter pylori with clarithromycin-containing regimens.
    Helicobacter. 2017 Nov 26. doi: 10.1111/hel.12452.
    PubMed     Text format     Abstract available


  15. NG QX, Venkatanarayanan N, De Deyn MLZQ, Ho CYX, et al
    A meta-analysis of the association between Helicobacter pylori (H. pylori) infection and hyperemesis gravidarum.
    Helicobacter. 2017 Nov 26. doi: 10.1111/hel.12455.
    PubMed     Text format     Abstract available


  16. HAYS C, Burucoa C, Lehours P, Tran CT, et al
    Molecular characterization of Helicobacter pylori resistance to rifamycins.
    Helicobacter. 2017 Nov 23. doi: 10.1111/hel.12451.
    PubMed     Text format     Abstract available


  17. KAWAKUBO M, Horiuchi K, Matsumoto T, Nakayama J, et al
    Cholesterol-alpha-glucosyltransferase gene is present in most Helicobacter species including gastric non-Helicobacter pylori helicobacters obtained from Japanese patients.
    Helicobacter. 2017 Nov 7. doi: 10.1111/hel.12449.
    PubMed     Text format     Abstract available


  18. FIORINI G, Saracino IM, Zullo A, Gatta L, et al
    Rescue therapy with bismuth quadruple regimen in patients with Helicobacter pylori -resistant strains.
    Helicobacter. 2017 Nov 1. doi: 10.1111/hel.12448.
    PubMed     Text format     Abstract available


    October 2017
  19. PASTUKH N, Binyamin D, On A, Paritsky M, et al
    GenoType(R) HelicoDR test in comparison with histology and culture for Helicobacter pylori detection and identification of resistance mutations to clarithromycin and fluoroquinolones.
    Helicobacter. 2017 Oct 23. doi: 10.1111/hel.12447.
    PubMed     Text format     Abstract available


  20. RAAF N, Amhis W, Saoula H, Abid A, et al
    Prevalence, antibiotic resistance, and MLST typing of Helicobacter pylori in Algiers, Algeria.
    Helicobacter. 2017 Oct 16. doi: 10.1111/hel.12446.
    PubMed     Text format     Abstract available


  21. TAKEOKA A, Tayama J, Kobayashi M, Sagara I, et al
    Psychological effects of Helicobacter pylori-associated atrophic gastritis in patients under 50 years: A cross-sectional study.
    Helicobacter. 2017 Oct 16. doi: 10.1111/hel.12445.
    PubMed     Text format     Abstract available


  22. ATILGAN CU, Kosekahya P, Yozgat A, Sen E, et al
    Are optic nerve heads of patients with helicobacter pylori infection more susceptible to glaucomatous damage?
    Helicobacter. 2017 Oct 5. doi: 10.1111/hel.12443.
    PubMed     Text format     Abstract available


    September 2017
  23. KHADANGI F, Yassi M, Kerachian MA
    Diagnostic accuracy of PCR-based detection tests for Helicobacter Pylori in stool samples: A systematic review and meta-analysis.
    Helicobacter. 2017 Sep 29. doi: 10.1111/hel.12444.
    PubMed     Text format     Abstract available


  24. WANGDA S, Richter JM, Kuenzang P, Wangchuk K, et al
    Epidemiology of Helicobacter pylori infection in asymptomatic schoolchildren in Bhutan.
    Helicobacter. 2017 Sep 22. doi: 10.1111/hel.12439.
    PubMed     Text format     Abstract available


  25. KIM SY, Lee SW, Choe JW, Jung SW, et al
    Helicobacter pylori eradication rates of concomitant and sequential therapies in Korea.
    Helicobacter. 2017 Sep 21. doi: 10.1111/hel.12441.
    PubMed     Text format     Abstract available


  26. MACIAS-GARCIA F, Llovo-Taboada J, Diaz-Lopez M, Baston-Rey I, et al
    High primary antibiotic resistance of Helicobacter Pylori strains isolated from dyspeptic patients: A prevalence cross-sectional study in Spain.
    Helicobacter. 2017 Sep 15. doi: 10.1111/hel.12440.
    PubMed     Text format     Abstract available


  27. DONG SQ, Singh TP, Wei X, Yao H, et al
    A Japanese population-based meta-analysis of vonoprazan versus PPI for Helicobacter pylori eradication therapy: Is superiority an illusion?
    Helicobacter. 2017 Sep 8. doi: 10.1111/hel.12438.
    PubMed     Text format     Abstract available


  28. KALACH N, Bontems P, Raymond J
    Helicobacter pylori infection in children.
    Helicobacter. 2017;22 Suppl 1.
    PubMed     Text format     Abstract available


  29. BURUCOA C, Axon A
    Epidemiology of Helicobacter pylori infection.
    Helicobacter. 2017;22 Suppl 1.
    PubMed     Text format     Abstract available


  30. O'CONNOR A, Lamarque D, Gisbert JP, O'Morain C, et al
    Treatment of Helicobacter pylori infection 2017.
    Helicobacter. 2017;22 Suppl 1.
    PubMed     Text format     Abstract available


  31. SJOMINA O, Heluwaert F, Moussata D, Leja M, et al
    Helicobacter pylori infection and nonmalignant diseases.
    Helicobacter. 2017;22 Suppl 1.
    PubMed     Text format     Abstract available


  32. BESSEDE E, Arantes V, Megraud F, Coelho LG, et al
    Diagnosis of Helicobacter pylori infection.
    Helicobacter. 2017;22 Suppl 1.
    PubMed     Text format     Abstract available


  33. DE KORWIN JD, Ianiro G, Gibiino G, Gasbarrini A, et al
    Helicobacter pylori infection and extragastric diseases in 2017.
    Helicobacter. 2017;22 Suppl 1.
    PubMed     Text format     Abstract available


  34. THORELL K, Lehours P, Vale FF
    Genomics of Helicobacter pylori.
    Helicobacter. 2017;22 Suppl 1.
    PubMed     Text format     Abstract available


  35. CAMILO V, Sugiyama T, Touati E
    Pathogenesis of Helicobacter pylori infection.
    Helicobacter. 2017;22 Suppl 1.
    PubMed     Text format     Abstract available


  36. VENERITO M, Vasapolli R, Rokkas T, Delchier JC, et al
    Helicobacter pylori, gastric cancer and other gastrointestinal malignancies.
    Helicobacter. 2017;22 Suppl 1.
    PubMed     Text format     Abstract available


    August 2017
  37. GUO L, Yin R, Xu G, Gong X, et al
    Immunologic properties and therapeutic efficacy of a multivalent epitope-based vaccine against four Helicobacter pylori adhesins (urease, Lpp20, HpaA, and CagL) in Mongolian gerbils.
    Helicobacter. 2017 Aug 29. doi: 10.1111/hel.12428.
    PubMed     Text format     Abstract available


  38. KWON YH, Kim JY, Kim N, Park JH, et al
    Specific mutations of penicillin-binding protein 1A in 77 clinically acquired amoxicillin-resistant Helicobacter pylori strains in comparison with 77 amoxicillin-susceptible strains.
    Helicobacter. 2017 Aug 25. doi: 10.1111/hel.12437.
    PubMed     Text format     Abstract available


  39. MIEHLKE S, Frederking D, Gunther T, Glocker E, et al
    Efficacy of three-in-one capsule bismuth quadruple therapy for Helicobacter pylori eradication in clinical practice in a multinational patient population.
    Helicobacter. 2017 Aug 22. doi: 10.1111/hel.12429.
    PubMed     Text format     Abstract available


  40. CHOI SH, Kim DM, Lee J, Yun NR, et al
    Endoscopic characteristics of infection-associated peptic ulcers.
    Helicobacter. 2017 Aug 18. doi: 10.1111/hel.12427.
    PubMed     Text format     Abstract available


  41. LIU W, Tan Z, Liu H, Zeng Z, et al
    Nongenetically modified Lactococcus lactis-adjuvanted vaccination enhanced innate immunity against Helicobacter pylori.
    Helicobacter. 2017 Aug 14. doi: 10.1111/hel.12426.
    PubMed     Text format     Abstract available


  42. GINESTET F, Guibourg B, Doucet L, Thereaux J, et al
    Upfront immunohistochemistry improves specificity of Helicobacter pylori diagnosis. A French pathology laboratory point of view.
    Helicobacter. 2017 Aug 11. doi: 10.1111/hel.12424.
    PubMed     Text format     Abstract available


  43. TSUDA M, Asaka M, Kato M, Matsushima R, et al
    Effect on Helicobacter pylori eradication therapy against gastric cancer in Japan.
    Helicobacter. 2017 Aug 3. doi: 10.1111/hel.12415.
    PubMed     Text format     Abstract available


  44. RODRIGUEZ DE SANTIAGO E, Martin de Argila de Prados C, Marcos Prieto HM, Jorge Turrion MA, et al
    Limited effectiveness with a 10-day bismuth-containing quadruple therapy (Pylera(R) ) in third-line recue treatment for Helicobacter pylori infection. A real-life multicenter study.
    Helicobacter. 2017 Aug 3. doi: 10.1111/hel.12423.
    PubMed     Text format     Abstract available


  45. ZHOU X, Su J, Zhu L, Zhang G, et al
    Helicobacter pylori modulates cisplatin sensitivity in gastric cancer by down-regulating miR-141 expression.
    Helicobacter. 2017;22.
    PubMed     Text format    


    July 2017
  46. FERNANDEZ-DE-LARREA N, Michel A, Romero B, Butt J, et al
    Antibody reactivity against Helicobacter pylori proteins in a sample of the Spanish adult population in 2008-2013.
    Helicobacter. 2017 Jul 24. doi: 10.1111/hel.12401.
    PubMed     Text format     Abstract available


    June 2017
  47. BUTENKO T, Jeverica S, Orel R, Homan M, et al
    Antibacterial resistance and the success of tailored triple therapy in Helicobacter pylori strains isolated from Slovenian children.
    Helicobacter. 2017 Jun 27. doi: 10.1111/hel.12400.
    PubMed     Text format     Abstract available


  48. ZABALA TORRRES B, Lucero Y, Lagomarcino AJ, Orellana-Manzano A, et al
    Prevalence and dynamics of Helicobacter pylori infection during childhood.
    Helicobacter. 2017 Jun 23. doi: 10.1111/hel.12399.
    PubMed     Text format     Abstract available


  49. SHEN X, Yang H, Wu Y, Zhang D, et al
    Association of Helicobacter pylori infection with Parkinson's diseases: A meta-analysis.
    Helicobacter. 2017 Jun 9. doi: 10.1111/hel.12398.
    PubMed     Text format     Abstract available


    May 2017
  50. OSAKI T, Mabe K, Zaman C, Yonezawa H, et al
    Usefulness of detection of clarithromycin-resistant Helicobacter pylori from fecal specimens for young adults treated with eradication therapy.
    Helicobacter. 2017 May 22. doi: 10.1111/hel.12396.
    PubMed     Text format     Abstract available


  51. SECKA O, Vale FF, Buissonniere A, Thomas JE, et al
    Phylogeographic agreement between prophage and bacterial housekeeping genes in Helicobacter pylori strains from The Gambia.
    Helicobacter. 2017 May 22. doi: 10.1111/hel.12394.
    PubMed     Text format    


  52. SHEHATA MA, Talaat R, Soliman S, Elmesseri H, et al
    Randomized controlled study of a novel triple nitazoxanide (NTZ)-containing therapeutic regimen versus the traditional regimen for eradication of Helicobacter pylori infection.
    Helicobacter. 2017 May 19. doi: 10.1111/hel.12395.
    PubMed     Text format     Abstract available


    April 2017
  53. BOEHNKE KF, Eaton KA, Fontaine C, Brewster R, et al
    Reduced infectivity of waterborne viable but nonculturable Helicobacter pylori strain SS1 in mice.
    Helicobacter. 2017 Apr 24. doi: 10.1111/hel.12391.
    PubMed     Text format     Abstract available


  54. SILVA B, Nunes A, Vale FF, Rocha R, et al
    The expression of Helicobacter pylori tfs plasticity zone cluster is regulated by pH and adherence, and its composition is associated with differential gastric IL-8 secretion.
    Helicobacter. 2017 Apr 24. doi: 10.1111/hel.12390.
    PubMed     Text format     Abstract available


  55. JUNG YS, Park CH, Park JH, Nam E, et al
    Efficacy of Helicobacter pylori eradication therapies in Korea: A systematic review and network meta-analysis.
    Helicobacter. 2017 Apr 19. doi: 10.1111/hel.12389.
    PubMed     Text format     Abstract available


  56. KOCSMAR E, Szirtes I, Kramer Z, Szijarto A, et al
    Sensitivity of Helicobacter pylori detection by Giemsa staining is poor in comparison with immunohistochemistry and fluorescent in situ hybridization and strongly depends on inflammatory activity.
    Helicobacter. 2017 Apr 12. doi: 10.1111/hel.12387.
    PubMed     Text format     Abstract available


  57. ANSARI S, Yamaoka Y
    Survival of Helicobacter pylori in gastric acidic territory.
    Helicobacter. 2017 Apr 12. doi: 10.1111/hel.12386.
    PubMed     Text format     Abstract available


  58. LEE AY, Kao CY, Wang YK, Lin SY, et al
    Inactivation of ferric uptake regulator (Fur) attenuates Helicobacter pylori J99 motility by disturbing the flagellar motor switch and autoinducer-2 production.
    Helicobacter. 2017 Apr 12. doi: 10.1111/hel.12388.
    PubMed     Text format     Abstract available


  59. AL-SINANI S, Al-Mulaabed SW, Al-Naamani K, Al-Sharji H, et al
    Helicobacter Pylori infection in Omani children.
    Helicobacter. 2017;22.
    PubMed     Text format    


    March 2017
  60. CHENG HC, Tsai YC, Yang HB, Yeh YC, et al
    The corpus-predominant gastritis index can be an early and reversible marker to identify the gastric cancer risk of Helicobacter pylori-infected nonulcer dyspepsia.
    Helicobacter. 2017 Mar 22. doi: 10.1111/hel.12385.
    PubMed     Text format     Abstract available


  61. KOTILEA K, Mekhael J, Salame A, Mahler T, et al
    Eradication rate of Helicobacter Pylori infection is directly influenced by adherence to therapy in children.
    Helicobacter. 2017 Mar 17. doi: 10.1111/hel.12383.
    PubMed     Text format     Abstract available


  62. BARTELS LE, Jepsen P, Tottrup A, Vilstrup H, et al
    Helicobacter pylori infection is associated with reduced prevalence of colonic diverticular disease.
    Helicobacter. 2017 Mar 16. doi: 10.1111/hel.12384.
    PubMed     Text format     Abstract available


  63. OLEASTRO M, Rocha R, Vale FF
    Population genetic structure of Helicobacter pylori strains from Portuguese-speaking countries.
    Helicobacter. 2017 Mar 8. doi: 10.1111/hel.12382.
    PubMed     Text format     Abstract available


    February 2017
  64. CHUAH YY, Wu DC, Chuah SK, Yang JC, et al
    Real-world practice and Expectation of Asia-Pacific physicians and patients in Helicobacter Pylori eradication (REAP-HP Survey).
    Helicobacter. 2017 Feb 28. doi: 10.1111/hel.12380.
    PubMed     Text format     Abstract available


  65. ALVAREZ A, Toledo H
    The histone-like protein HU has a role in gene expression during the acid adaptation response in Helicobacter pylori.
    Helicobacter. 2017 Feb 28. doi: 10.1111/hel.12381.
    PubMed     Text format     Abstract available


  66. NG GZ, Ke BX, Laskowski A, Thorburn DR, et al
    No evidence of a role for mitochondrial complex I in Helicobacter pylori pathogenesis.
    Helicobacter. 2017 Feb 9. doi: 10.1111/hel.12378.
    PubMed     Text format     Abstract available


    January 2017
  67. TURSI A, Di Mario F, Franceschi M, De Bastiani R, et al
    New bismuth-containing quadruple therapy in patients infected with Helicobacter pylori: A first Italian experience in clinical practice.
    Helicobacter. 2017 Jan 26. doi: 10.1111/hel.12371.
    PubMed     Text format     Abstract available


  68. KIM TJ, Kim ER, Chang DK, Kim YH, et al
    Helicobacter pylori infection is an independent risk factor of early and advanced colorectal neoplasm.
    Helicobacter. 2017 Jan 26. doi: 10.1111/hel.12377.
    PubMed     Text format     Abstract available


  69. TANAKA S, Nagashima H, Uotani T, Graham DY, et al
    Autophagy-related genes in Helicobacter pylori infection.
    Helicobacter. 2017 Jan 23. doi: 10.1111/hel.12376.
    PubMed     Text format     Abstract available


  70. ONO S, Kato M, Nakagawa S, Mabe K, et al
    Vonoprazan improves the efficacy of Helicobacter pylori eradication therapy with a regimen consisting of clarithromycin and metronidazole in patients allergic to penicillin.
    Helicobacter. 2017 Jan 18. doi: 10.1111/hel.12374.
    PubMed     Text format     Abstract available


  71. MORAIS S, Costa AR, Ferro A, Lunet N, et al
    Contemporary migration patterns in the prevalence of Helicobacter pylori infection: A systematic review.
    Helicobacter. 2017 Jan 18. doi: 10.1111/hel.12372.
    PubMed     Text format     Abstract available


  72. LI L, Ke Y, Yu C, Li G, et al
    Antibiotic resistance of Helicobacter pylori in Chinese children: A multicenter retrospective study over 7 years.
    Helicobacter. 2017 Jan 18. doi: 10.1111/hel.12373.
    PubMed     Text format     Abstract available


  73. SHEU BS, Wu MS, Chiu CT, Lo JC, et al
    Consensus on the clinical management, screening-to-treat, and surveillance of Helicobacter pylori infection to improve gastric cancer control on a nationwide scale.
    Helicobacter. 2017 Jan 8. doi: 10.1111/hel.12368.
    PubMed     Text format     Abstract available


    December 2016
  74. SONNENBERG A, Dellon ES, Turner KO, Genta RM, et al
    The influence of Helicobacter pylori on the ethnic distribution of esophageal eosinophilia.
    Helicobacter. 2016 Dec 28. doi: 10.1111/hel.12370.
    PubMed     Text format     Abstract available


  75. SHAMSDIN SA, Alborzi A, Rasouli M, Ghaderi A, et al
    The importance of TH22 and TC22 cells in the pathogenesis of Helicobacter pylori-associated gastric diseases.
    Helicobacter. 2016 Dec 19. doi: 10.1111/hel.12367.
    PubMed     Text format     Abstract available


  76. SUN X, Zhang M, El-Zaatari M, Huffnagle GB, et al
    CCR2 mediates Helicobacter pylori-induced immune tolerance and contributes to mucosal homeostasis.
    Helicobacter. 2016 Dec 8. doi: 10.1111/hel.12366.
    PubMed     Text format     Abstract available


    November 2016
  77. FERENC S, Gnus J, Koscielna M, Kinda M, et al
    High antibiotic resistance of Helicobacter pylori and its effect on tailored and empiric eradication of the organism in Lower Silesia, Poland.
    Helicobacter. 2016 Nov 23. doi: 10.1111/hel.12365.
    PubMed     Text format     Abstract available


    October 2016
  78. DEN HOLLANDER WJ, Schalekamp-Timmermans S, Holster IL, Jaddoe VW, et al
    Helicobacter pylori colonization and pregnancies complicated by preeclampsia, spontaneous prematurity, and small for gestational age birth.
    Helicobacter. 2016 Oct 27. doi: 10.1111/hel.12364.
    PubMed     Text format     Abstract available


  79. NAKAYAMA Y, Lin Y, Hongo M, Hidaka H, et al
    Helicobacter pylori infection and its related factors in junior high school students in Nagano Prefecture, Japan.
    Helicobacter. 2016 Oct 27. doi: 10.1111/hel.12363.
    PubMed     Text format     Abstract available


  80. ZHOU L, Zhao F, Hu B, Fang Y, et al
    A Creative Helicobacter pylori Diagnosis Scheme Based on Multiple Genetic Analysis System: Qualification and Quantitation.
    Helicobacter. 2016;21:441.
    PubMed     Text format    


    September 2016
  81. MIHARA H, Suzuki N, Muhammad JS, Nanjo S, et al
    Transient receptor potential vanilloid 4 (TRPV4) silencing in Helicobacter pylori-infected human gastric epithelium.
    Helicobacter. 2016 Sep 30. doi: 10.1111/hel.12361.
    PubMed     Text format     Abstract available


  82. ABDUL RAHIM NR, Benson J, Grocke K, Vather D, et al
    Prevalence of Helicobacter pylori infection in newly arrived refugees attending the Migrant Health Service, South Australia.
    Helicobacter. 2016 Sep 22. doi: 10.1111/hel.12360.
    PubMed     Text format     Abstract available


  83. PONZETTO A, Figura N
    Helicobacter pylori and preeclampsia.
    Helicobacter. 2016 Sep 7. doi: 10.1111/hel.12359.
    PubMed     Text format    


  84. O'CONNOR A, Fischbach W, Gisbert JP, O'Morain C, et al
    Treatment of Helicobacter pylori infection 2016.
    Helicobacter. 2016;21 Suppl 1:55-61.
    PubMed     Text format     Abstract available


  85. SUSTMANN A, Okuda M, Koletzko S
    Helicobacter pylori in children.
    Helicobacter. 2016;21 Suppl 1:49-54.
    PubMed     Text format     Abstract available


  86. GONI E, Franceschi F
    Helicobacter pylori and extragastric diseases.
    Helicobacter. 2016;21 Suppl 1:45-8.
    PubMed     Text format     Abstract available


  87. VASAPOLLI R, Malfertheiner P, Kandulski A
    Helicobacter pylori and non-malignant upper gastrointestinal diseases.
    Helicobacter. 2016;21 Suppl 1:30-3.
    PubMed     Text format     Abstract available


  88. VELIN D, Straubinger K, Gerhard M
    Inflammation, immunity, and vaccines for Helicobacter pylori infection.
    Helicobacter. 2016;21 Suppl 1:26-9.
    PubMed     Text format     Abstract available


  89. BACKERT S, Neddermann M, Maubach G, Naumann M, et al
    Pathogenesis of Helicobacter pylori infection.
    Helicobacter. 2016;21 Suppl 1:19-25.
    PubMed     Text format     Abstract available


  90. BERTHENET E, Sheppard S, Vale FF
    Recent "omics" advances in Helicobacter pylori.
    Helicobacter. 2016;21 Suppl 1:14-8.
    PubMed     Text format     Abstract available


  91. MEGRAUD F, Floch P, Labenz J, Lehours P, et al
    Diagnostic of Helicobacter pylori infection.
    Helicobacter. 2016;21 Suppl 1:8-13.
    PubMed     Text format     Abstract available


  92. LEJA M, Axon A, Brenner H
    Epidemiology of Helicobacter pylori infection.
    Helicobacter. 2016;21 Suppl 1:3-7.
    PubMed     Text format     Abstract available


    August 2016
  93. HARMATI M, Gyukity-Sebestyen E, Dobra G, Terhes G, et al
    Binary mixture of Satureja hortensis and Origanum vulgare subsp. hirtum essential oils: in vivo therapeutic efficiency against Helicobacter pylori infection.
    Helicobacter. 2016 Aug 31. doi: 10.1111/hel.12350.
    PubMed     Text format     Abstract available


  94. ZOU M, Wang F, Jiang A, Xia A, et al
    MicroRNA-3178 ameliorates inflammation and gastric carcinogenesis promoted by Helicobacter pylori new toxin, Tip-alpha, by targeting TRAF3.
    Helicobacter. 2016 Aug 5. doi: 10.1111/hel.12348.
    PubMed     Text format     Abstract available


  95. DI SIMONE N, Tersigni C, Cardaropoli S, Franceschi F, et al
    Helicobacter pylori infection contributes to placental impairment in preeclampsia: basic and clinical evidences.
    Helicobacter. 2016 Aug 3. doi: 10.1111/hel.12347.
    PubMed     Text format     Abstract available


    July 2016
  96. HUDAK L, Jaraisy A, Haj S, Muhsen K, et al
    An updated systematic review and meta-analysis on the association between Helicobacter pylori infection and iron deficiency anemia.
    Helicobacter. 2016 Jul 13. doi: 10.1111/hel.12330.
    PubMed     Text format     Abstract available


  97. MABE K, Kikuchi S, Okuda M, Takamasa M, et al
    Diagnostic accuracy of urine Helicobacter pylori antibody test in junior and senior high school students in Japan.
    Helicobacter. 2016 Jul 11. doi: 10.1111/hel.12329.
    PubMed     Text format     Abstract available


  98. REGNATH T, Raecke O, Enninger A, Ignatius R, et al
    Increasing metronidazole and rifampicin resistance of Helicobacter pylori isolates obtained from children and adolescents between 2002 and 2015 in southwest Germany.
    Helicobacter. 2016 Jul 11. doi: 10.1111/hel.12327.
    PubMed     Text format     Abstract available


    June 2016
  99. PEREZ-RODRIGUEZ M, Partida-Rodriguez O, Camorlinga-Ponce M, Flores-Luna L, et al
    Polymorphisms in HLA-DQ genes, together with age, sex, and Helicobacter pylori infection, as potential biomarkers for the early diagnosis of gastric cancer.
    Helicobacter. 2016 Jun 23. doi: 10.1111/hel.12326.
    PubMed     Text format     Abstract available


  100. SMITH SM, Freeley M, Moynagh PN, Kelleher DP, et al
    Differential modulation of Helicobacter pylori lipopolysaccharide-mediated TLR2 signaling by individual Pellino proteins.
    Helicobacter. 2016 Jun 15. doi: 10.1111/hel.12325.
    PubMed     Text format     Abstract available


  101. YOU-HUA W, Lv ZF, Zhong Y, Liu DS, et al
    The internalization of Helicobacter pylori plays a role in the failure of H. pylori eradication.
    Helicobacter. 2016 Jun 10. doi: 10.1111/hel.12324.
    PubMed     Text format     Abstract available


  102. KUMAR N, Albert MJ, Al Abkal H, Siddique I, et al
    What constitutes an Arabian Helicobacter pylori? Lessons from comparative genomics.
    Helicobacter. 2016 Jun 9. doi: 10.1111/hel.12323.
    PubMed     Text format     Abstract available


  103. TSUKANOV VV, Kasparov EV, Tonkikh JL, Shtygasheva OV, et al
    Peptic Ulcer Disease and Helicobacter pylori Infection in Different Siberian Ethnicities.
    Helicobacter. 2016 Jun 6. doi: 10.1111/hel.12322.
    PubMed     Text format     Abstract available


  104. LEE WC, Goh KL, Loke MF, Vadivelu J, et al
    Elucidation of the Metabolic Network of Helicobacter pylori J99 and Malaysian Clinical Strains by Phenotype Microarray.
    Helicobacter. 2016 Jun 3. doi: 10.1111/hel.12321.
    PubMed     Text format     Abstract available


    May 2016
  105. GEORGE S, Mamani N, Lucero Y, Torres JP, et al
    Detection of Helicobacter pylori by Real-Time PCR for 16s rRNA in Stools of NonInfected Healthy Children, Using ELISA Antigen Stool Test as the Gold Standard.
    Helicobacter. 2016 May 23. doi: 10.1111/hel.12318.
    PubMed     Text format     Abstract available


  106. SUGIMOTO M, Sahara S, Ichikawa H, Kagami T, et al
    Four-times-daily Dosing of Rabeprazole with Sitafloxacin, High-Dose Amoxicillin, or Both for Metronidazole-Resistant Infection with Helicobacter pylori in Japan.
    Helicobacter. 2016 May 23. doi: 10.1111/hel.12319.
    PubMed     Text format     Abstract available


  107. OH S, Kim N, Kwon JW, Shin CM, et al
    Effect of Helicobacter pylori Eradication and ABO Genotype on Gastric Cancer Development.
    Helicobacter. 2016 May 18. doi: 10.1111/hel.12317.
    PubMed     Text format     Abstract available


  108. BRECKAN RK, Paulssen EJ, Asfeldt AM, Kvamme JM, et al
    The All-Age Prevalence of Helicobacter pylori Infection and Potential Transmission Routes. A Population-Based Study.
    Helicobacter. 2016 May 12. doi: 10.1111/hel.12316.
    PubMed     Text format     Abstract available


    April 2016
  109. DORE MP, Pes GM, Sferlazzo G, Marras G, et al
    Role of Helicobacter pylori Infection in Body Height of Adult Dyspeptic Patients.
    Helicobacter. 2016 Apr 20. doi: 10.1111/hel.12314.
    PubMed     Text format     Abstract available


  110. TAN RJ, Sun HQ, Zhang W, Yuan HM, et al
    A 21-35 kDa Mixed Protein Component from Helicobacter pylori Activates Mast Cells Effectively in Chronic Spontaneous Urticaria.
    Helicobacter. 2016 Apr 8. doi: 10.1111/hel.12312.
    PubMed     Text format     Abstract available


  111. YILDIRIM Z, Bozkurt B, Ozol D, Armutcu F, et al
    Increased Exhaled 8-Isoprostane and Interleukin-6 in Patients with Helicobacter pylori Infection.
    Helicobacter. 2016 Apr 8. doi: 10.1111/hel.12302.
    PubMed     Text format     Abstract available


  112. WAN XK, Yuan SL, Tao HX, Diao LP, et al
    The Upregulation of TRAF1 Induced by Helicobacter pylori Plays an Antiapoptotic Effect on the Infected Cells.
    Helicobacter. 2016 Apr 6. doi: 10.1111/hel.12311.
    PubMed     Text format     Abstract available


  113. SONG Z, Suo B, Zhang L, Zhou L, et al
    Rabeprazole, Minocycline, Amoxicillin, and Bismuth as First-Line and Second-Line Regimens for Helicobacter pylori Eradication.
    Helicobacter. 2016 Apr 6. doi: 10.1111/hel.12313.
    PubMed     Text format     Abstract available


    March 2016
  114. BLASE JL, Campbell PT, Gapstur SM, Pawlita M, et al
    Prediagnostic Helicobacter pylori Antibodies and Colorectal Cancer Risk in an Elderly, Caucasian Population.
    Helicobacter. 2016 Mar 23. doi: 10.1111/hel.12305.
    PubMed     Text format     Abstract available


  115. WEN G, Jin H, Deng S, Xu J, et al
    Effects of Helicobacter pylori Infection on the Expressions and Functional Activities of Human Duodenal Mucosal Bicarbonate Transport Proteins.
    Helicobacter. 2016 Mar 23. doi: 10.1111/hel.12309.
    PubMed     Text format     Abstract available


  116. OH B, Kim JW, Kim BS
    Changes in the Functional Potential of the Gut Microbiome Following Probiotic Supplementation during Helicobacter Pylori Treatment.
    Helicobacter. 2016 Mar 18. doi: 10.1111/hel.12306.
    PubMed     Text format     Abstract available


  117. PALAU M, Kulmann M, Ramirez-Lazaro MJ, Lario S, et al
    Usefulness of Housekeeping Genes for the Diagnosis of Helicobacter pylori Infection, Strain Discrimination and Detection of Multiple Infection.
    Helicobacter. 2016 Mar 18. doi: 10.1111/hel.12304.
    PubMed     Text format     Abstract available


  118. BERRETT AN, Gale SD, Erickson LD, Brown BL, et al
    Folate and Inflammatory Markers Moderate the Association Between Helicobacter pylori Exposure and Cognitive Function in US Adults.
    Helicobacter. 2016 Mar 3. doi: 10.1111/hel.12303.
    PubMed     Text format     Abstract available


  119. LI H, Liao T, Debowski AW, Tang H, et al
    Lipopolysaccharide Structure and Biosynthesis in Helicobacter pylori.
    Helicobacter. 2016 Mar 2. doi: 10.1111/hel.12301.
    PubMed     Text format     Abstract available


    February 2016
  120. JO HJ, Kim J, Kim N, Park JH, et al
    Analysis of Gastric Microbiota by Pyrosequencing: Minor Role of Bacteria Other Than Helicobacter pylori in the Gastric Carcinogenesis.
    Helicobacter. 2016 Feb 24. doi: 10.1111/hel.12293.
    PubMed     Text format     Abstract available


  121. PIAO JY, Lee HG, Kim SJ, Kim DH, et al
    Helicobacter pylori Activates IL-6-STAT3 Signaling in Human Gastric Cancer Cells: Potential Roles for Reactive Oxygen Species.
    Helicobacter. 2016 Feb 23. doi: 10.1111/hel.12298.
    PubMed     Text format     Abstract available


  122. HE C, Yang Z, Lu N
    Imbalance of Gastrointestinal Microbiota in the Pathogenesis of Helicobacter pylori-Associated Diseases.
    Helicobacter. 2016 Feb 15. doi: 10.1111/hel.12297.
    PubMed     Text format     Abstract available


    January 2016
  123. HU Y, Zhang M, Lu B, Dai J, et al
    Helicobacter pylori and Antibiotic Resistance, A Continuing and Intractable Problem.
    Helicobacter. 2016 Jan 29. doi: 10.1111/hel.12299.
    PubMed     Text format     Abstract available


  124. BANERJEE A, Basu M, Blanchard TG, Chintalacharuvu SR, et al
    Early Molecular Events in Murine Gastric Epithelial Cells Mediated by Helicobacter pylori CagA.
    Helicobacter. 2016 Jan 28. doi: 10.1111/hel.12300.
    PubMed     Text format     Abstract available


  125. SINGH A, Blaskovic D, Joo J, Yang Z, et al
    Investigating the Role of Helicobacter pylori PriA Protein.
    Helicobacter. 2016 Jan 28. doi: 10.1111/hel.12283.
    PubMed     Text format     Abstract available


  126. SONG Z, Zhou L, Zhang J, He L, et al
    Hybrid Therapy as First-Line Regimen for Helicobacter pylori Eradication in Populations with High Antibiotic Resistance Rates.
    Helicobacter. 2016 Jan 25. doi: 10.1111/hel.12294.
    PubMed     Text format     Abstract available


  127. CICCAGLIONE AF, Tavani R, Grossi L, Cellini L, et al
    Rifabutin Containing Triple Therapy and Rifabutin with Bismuth Containing Quadruple Therapy for Third-Line Treatment of Helicobacter pylori Infection: Two Pilot Studies.
    Helicobacter. 2016 Jan 25. doi: 10.1111/hel.12296.
    PubMed     Text format     Abstract available


  128. SUKRI A, Hanafiah A, Kosai NR, Mohamed Taher M, et al
    Surface Antigen Profiling of Helicobacter pylori-Infected and -Uninfected Gastric Cancer Cells Using Antibody Microarray.
    Helicobacter. 2016 Jan 25. doi: 10.1111/hel.12295.
    PubMed     Text format     Abstract available


  129. ANG TL, Fock KM, Ang D, Kwek AB, et al
    The Changing Profile of Helicobacter pylori Antibiotic Resistance in Singapore: A 15-Year Study.
    Helicobacter. 2016 Jan 15. doi: 10.1111/hel.12291.
    PubMed     Text format     Abstract available


  130. HU Y, Liu JP, Zhu Y, Lu NH, et al
    The Importance of Toll-like Receptors in NF-kappaB Signaling Pathway Activation by Helicobacter pylori Infection and the Regulators of this Response.
    Helicobacter. 2016 Jan 13. doi: 10.1111/hel.12292.
    PubMed     Text format     Abstract available


    December 2015
  131. TALARICO S, Safaeian M, Gonzalez P, Hildesheim A, et al
    Quantitative Detection and Genotyping of Helicobacter pylori from Stool using Droplet Digital PCR Reveals Variation in Bacterial Loads that Correlates with cagA Virulence Gene Carriage.
    Helicobacter. 2015 Dec 15. doi: 10.1111/hel.12289.
    PubMed     Text format     Abstract available


  132. ERDEMIR G, Ozkan TB, Ozgur T, Altay D, et al
    Helicobacter pylori Infection in Children: Nutritional Status and Associations with Serum Leptin, Ghrelin, and IGF-1 Levels.
    Helicobacter. 2015 Dec 15. doi: 10.1111/hel.12288.
    PubMed     Text format     Abstract available


  133. UNLER GK, Teke Ozgur G, Gokturk HS, Karakoca A, et al
    A Comparison of Five Different Treatment Regimens as the First-Line Treatment of Helicobacter pylori in Turkey.
    Helicobacter. 2015 Dec 1. doi: 10.1111/hel.12285.
    PubMed     Text format     Abstract available


    November 2015
  134. MORI H, Suzuki H, Matsuzaki J, Tsugawa H, et al
    Efficacy of 10-day Sitafloxacin-Containing Third-Line Rescue Therapies for Helicobacter pylori Strains Containing the gyrA Mutation.
    Helicobacter. 2015 Nov 27. doi: 10.1111/hel.12286.
    PubMed     Text format     Abstract available


  135. BAKHTI SZ, Latifi-Navid S, Mohammadi S, Zahri S, et al
    Relevance of Helicobacter pylori vacA 3'-end Region Polymorphism to Gastric Cancer.
    Helicobacter. 2015 Nov 27. doi: 10.1111/hel.12284.
    PubMed     Text format     Abstract available


  136. KYRILLOS A, Arora G, Murray B, Rosenwald AG, et al
    The Presence of Phage Orthologous Genes in Helicobacter pylori Correlates with the Presence of the Virulence Factors CagA and VacA.
    Helicobacter. 2015 Nov 27. doi: 10.1111/hel.12282.
    PubMed     Text format     Abstract available


    October 2015
  137. SHIN WG, Lee SW, Baik GH, Huh KC, et al
    Eradication Rates of Helicobacter pylori in Korea Over the Past 10 years and Correlation of the Amount of Antibiotics Use: Nationwide Survey.
    Helicobacter. 2015 Oct 16. doi: 10.1111/hel.12279.
    PubMed     Text format     Abstract available


    September 2015
  138. KIM JM, Choe MH, Asaithambi K, Song JY, et al
    Helicobacter pylori HP0425 Targets the Nucleus with DNase I-Like Activity.
    Helicobacter. 2015 Sep 23. doi: 10.1111/hel.12271.
    PubMed     Text format     Abstract available


  139. OH B, Kim BS, Kim JW, Kim JS, et al
    The Effect of Probiotics on Gut Microbiota during the Helicobacter pylori Eradication: Randomized Controlled Trial.
    Helicobacter. 2015 Sep 23. doi: 10.1111/hel.12270.
    PubMed     Text format     Abstract available


  140. AGREUS L, Talley NJ, Jones M
    Value of the "Test & Treat" Strategy for Uninvestigated Dyspepsia at Low Prevalence Rates of Helicobacter pylori in the Population.
    Helicobacter. 2015 Sep 8. doi: 10.1111/hel.12267.
    PubMed     Text format     Abstract available


  141. SHAN W, Kung HF, Ge R
    Comparison of Iron-Binding Ability Between Thr70-NapA and Ser70-NapA of Helicobacter pylori.
    Helicobacter. 2015 Sep 8. doi: 10.1111/hel.12266.
    PubMed     Text format     Abstract available


  142. CHAI FY, Chong HC, Tan YE, Heng SS, et al
    Helicobacter pylori Infection Rates in Patients Undergoing Endoscopy in the Interior of Borneo.
    Helicobacter. 2015 Sep 8. doi: 10.1111/hel.12264.
    PubMed     Text format     Abstract available


  143. LI Y, Chen Z, Ye J, Ning L, et al
    Antibody Production and Th1-biased Response Induced by an Epitope Vaccine Composed of Cholera Toxin B Unit and Helicobacter pylori Lpp20 Epitopes.
    Helicobacter. 2015 Sep 2. doi: 10.1111/hel.12268.
    PubMed     Text format     Abstract available


  144. O'CONNOR A, Gisbert JP, O'Morain C, Ladas S, et al
    Treatment of Helicobacter pylori Infection 2015.
    Helicobacter. 2015;20 Suppl 1:54-61.
    PubMed     Text format     Abstract available


  145. ROMA E, Miele E
    Helicobacter pylori Infection in Pediatrics.
    Helicobacter. 2015;20 Suppl 1:47-53.
    PubMed     Text format     Abstract available


  146. FRANCESCHI F, Gasbarrini A, Polyzos SA, Kountouras J, et al
    Extragastric Diseases and Helicobacter pylori.
    Helicobacter. 2015;20 Suppl 1:40-6.
    PubMed     Text format     Abstract available


  147. VENERITO M, Vasapolli R, Rokkas T, Malfertheiner P, et al
    Helicobacter pylori and Gastrointestinal Malignancies.
    Helicobacter. 2015;20 Suppl 1:36-9.
    PubMed     Text format     Abstract available


  148. POTAMITIS GS, Axon AT
    Helicobacter pylori and Nonmalignant Diseases.
    Helicobacter. 2015;20 Suppl 1:26-9.
    PubMed     Text format     Abstract available


  149. WALDUCK A, Andersen LP, Raghavan S
    Inflammation, Immunity, and Vaccines for Helicobacter pylori Infection.
    Helicobacter. 2015;20 Suppl 1:17-25.
    PubMed     Text format     Abstract available


  150. SGOURAS DN, Trang TT, Yamaoka Y
    Pathogenesis of Helicobacter pylori Infection.
    Helicobacter. 2015;20 Suppl 1:8-16.
    PubMed     Text format     Abstract available


  151. MENTIS A, Lehours P, Megraud F
    Epidemiology and Diagnosis of Helicobacter pylori infection.
    Helicobacter. 2015;20 Suppl 1:1-7.
    PubMed     Text format     Abstract available


    August 2015
  152. CAMARGO MC, Kim KM, Matsuo K, Torres J, et al
    Anti-Helicobacter pylori Antibody Profiles in Epstein-Barr virus (EBV)-Positive and EBV-Negative Gastric Cancer.
    Helicobacter. 2015 Aug 7. doi: 10.1111/hel.12249.
    PubMed     Text format     Abstract available


    July 2015
  153. SANIEE P, Shahreza S, Siavoshi F
    Negative Effect of Proton-pump Inhibitors (PPIs) on Helicobacter pylori Growth, Morphology, and Urease Test and Recovery after PPI Removal - An In vitro Study.
    Helicobacter. 2015 Jul 28. doi: 10.1111/hel.12246.
    PubMed     Text format     Abstract available


  154. SERRANO CA, Villagran A, Toledo H, Crabtree JE, et al
    Iron Deficiency and IL1beta Polymorphisms in Helicobacter pylori-infected Children.
    Helicobacter. 2015 Jul 24. doi: 10.1111/hel.12247.
    PubMed     Text format     Abstract available


  155. OBAYASHI N, Ohtsuka Y, Hosoi K, Ikuse T, et al
    Comparison of Gene Expression Between Pediatric and Adult Gastric Mucosa with Helicobacter pylori Infection.
    Helicobacter. 2015 Jul 3. doi: 10.1111/hel.12245.
    PubMed     Text format     Abstract available


  156. TOYODA T, Shi L, Takasu S, Cho YM, et al
    Anti-Inflammatory Effects of Capsaicin and Piperine on Helicobacter pylori-Induced Chronic Gastritis in Mongolian Gerbils.
    Helicobacter. 2015 Jul 3. doi: 10.1111/hel.12243.
    PubMed     Text format     Abstract available


    June 2015
  157. ALIPOUR N, Gaeini N, Taner A, Yildiz F, et al
    Vacuoles of Acanthamoeba castellanii Behave as a Specialized Shelter (host) for Helicobacter pylori.
    Helicobacter. 2015 Jun 30. doi: 10.1111/hel.12233.
    PubMed     Text format     Abstract available


  158. GRAHAM DY
    Editorial - Avoiding Unethical Helicobacter pylori Clinical Trials: Susceptibility-Based Studies and Probiotics as Adjuvants.
    Helicobacter. 2015 Jun 30. doi: 10.1111/hel.12244.
    PubMed     Text format     Abstract available


  159. SCHWARZER A, Bontems P, Urruzuno P, Kalach N, et al
    Sequential Therapy for Helicobacter pylori Infection in Treatment-naive Children.
    Helicobacter. 2015 Jun 30. doi: 10.1111/hel.12240.
    PubMed     Text format     Abstract available


  160. ZHOU L, Zhang J, Song Z, He L, et al
    Tailored versus Triple plus Bismuth or Concomitant Therapy as Initial Helicobacter pylori Treatment: A Randomized Trial.
    Helicobacter. 2015 Jun 23. doi: 10.1111/hel.12242.
    PubMed     Text format     Abstract available


  161. DOLAPCIOGLU C, Sayiner M, Akkus EE, Kural A, et al
    First-line Bismuth-containing Five-day Concomitant Quintuple Therapy for Helicobacter Pylori Eradication.
    Helicobacter. 2015 Jun 23. doi: 10.1111/hel.12241.
    PubMed     Text format     Abstract available


    May 2015
  162. EMARA MH, Elhawari SA, Yousef S, Radwan MI, et al
    Emerging Role of Probiotics in the Management of Helicobacter Pylori Infection: Histopathologic Perspectives.
    Helicobacter. 2015 May 22. doi: 10.1111/hel.12237.
    PubMed     Text format     Abstract available


  163. MARCUS EA, Sachs G, Wen Y, Scott DR, et al
    Phosphorylation-dependent and Phosphorylation-independent Regulation of Helicobacter pylori Acid Acclimation by the ArsRS Two-component System.
    Helicobacter. 2015 May 22. doi: 10.1111/hel.12235.
    PubMed     Text format     Abstract available


  164. SUN J, Rangan P, Bhat SS, Liu L, et al
    A Meta-Analysis of the Association between Helicobacter pylori Infection and Risk of Coronary Heart Disease from Published Prospective Studies.
    Helicobacter. 2015 May 22. doi: 10.1111/hel.12234.
    PubMed     Text format     Abstract available


  165. AFYONCU O, Gursel O, Atay A, Kurekci E, et al
    Holotranscobalamin Levels in Children with Helicobacter Pylori Infection.
    Helicobacter. 2015 May 15. doi: 10.1111/hel.12232.
    PubMed     Text format     Abstract available


  166. COSME A, Lizasoan J, Montes M, Tamayo E, et al
    Antimicrobial Susceptibility-Guided Therapy Versus Empirical Concomitant Therapy for Eradication of Helicobacter pylori in a Region with High Rate of Clarithromycin Resistance.
    Helicobacter. 2015 May 15. doi: 10.1111/hel.12231.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Peptic Ulcer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: